Global Pharmaceutical Contract Manufacturing Market is expected to grow at a CAGR close to 7% during the forecast period of 2016-2020 :Top keyplayers are Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Dr. Reddy

Description

The Global Pharmaceutical Contract Manufacturing Market is expected to grow at a CAGR close to 7% during the forecast period of 2016-2020. The market for the pharmaceutical contract manufacturing is expected to grow positively for the coming years due to the increasing number of US FDA approved manufacturing facilities in the emerging countries. Many of the pharmaceutical companies look for the US FDA approved manufacturing facilities empowered with the skilled workforce and low operating costs while selecting any partner for outsourcing. For instance, with around 100 US FDA approved manufacturing facilities, India is one of the most looked out locations for the outsourcing of manufacturing services.

Request For Free Sample@ https://www.kennethresearch.com/sample-request-10065061

The pharmaceutical ranges are being expanded to include drugs with shorter shelf-life by the advancements in medical science, especially vaccinations, along with the other developments in nanotechnology and stem cell research. This has necessitated more composite manufacturing and distribution processes. To introduce new medicines for different diseases, several of the pharmaceutical companies are significantly investing in their R&D. Also, in an attempt to cater to the growing R&D requirements of the sourcing companies, CMOs are offering assistance in research.Additionally, a rise in research funding and support for clinical and support services has been observed due to the increased awareness about CMOs. This is further expected to drive the demand for outsourcing in the market.

Market Dynamics

The market was valued USD 65.10 billion in 2016 and is projected to reach USD 94.38 billion by 2022, at a CAGR of 6.36% during the forecast period, from 2017 to 2022.The growing need for the state-of-the-art processes and production technologies, which effectively meet the regulatory requirements, is the major factor driving the growth of pharmaceutical contract manufacturers (CMO) in the industry.

The patent expiration of major therapeutic brands, the growing demand for generic drugs and adoption of novel manufacturing technologies are some of the factors exerting a positive influence on this market. In order to stay competitive in the market, many of the pharma companies have been compelled to revisit their production processes and R&D of drugs. Thus, in this scenario, contract manufacturing ought's to be the best strategic option to boost the market grows exponentially.

Market Segmentation

Segmentation on the basis of contract manufacturing and analysis of the pharmaceutical contract manufacturing market:
Active pharmaceutical ingredient (API) /bulk drug manufacturing
Final dosage form (FDF)
During 2015, the market was led by the global API/bulk drug manufacturing segment which is also expected to dominate the market during the forecast period until 2020. One of the primary factors propelling this segment's growth is the sharp rise in the number of drug approvals. Also, the patent expiries of top-selling biologics create an opportunity to develop cost-effective biosimilars for the vendors and hence plays a major role in the market growth in North America. Thus, the API market in this region would be further strengthened by the expected market entry of biosimilars and generics.

Geographical segmentation:
Americas
APAC
EMEA

In terms of geography, the Americas were the highest revenue contributing region in the market and will continue to dominate the market during the forecast period. The growth of this market in the Americas is attributed to the increasing older population and higher uptake of biologicals. Also, the growing demand for generics and favorable initiatives taken by the governments in the pharmaceutical field and various research initiatives were taken by biotechnological companies will also drive market growth in the region.

Buy Now@ https://www.kennethresearch.com/report-purchase-id-10065061

Opportunities

The growth of the API market is fueled by the increase in the demand for abbreviated new drug applications (ANDA) and in filing drug master files (DMF) from the Indian companies. The development of biological APIs has been the prime focus of many of the companies in this market, which indirectly drives this market. The other factors such as stringent government initiatives in the healthcare sector, innovations in biologics and high potency API and rise in the incidence of cancer and age-related diseases have propelled the growth of the API market. By the end of the forecast period, the captive manufacturers are expected to lose their market share to the contract manufacturers in the API market. This has been the result of complex and expensive in-house manufacturing of API and rise in the competition from the emerging players in this industry.

Key Players

Key vendors in this market are -
Catalent
Lonza
Pfizer CentreOne

Some of the other important vendors in the market are Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Dr. Reddy's Laboratories, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Daiichi Sankyo, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Fareva, Gedeon Richter, Gilead Sciences, GlaxoSmithKline (GSK),Hospira, Impax Laboratories, Intas Pharmaceuticals, Janssen Pharmaceuticals, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Par Pharmaceutical, Parenteral Drugs India, Patheon, Piramal, Roche Holding, Sanofi, Synthon, Teva Pharmaceuticals, Valeant Pharmaceuticals, Zentiva, Zhejiang Huahai Pharmaceutical, and Zydus Cadila.

Report ContentsRegional AnalysisReport Highlights

Market Segments
Market Drivers, Restraints and Opportunities
Pharmaceutical Contract Manufacturing Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market - Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Russia
Poland
Rest of Eastern Europe

Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

Read More@ https://www.kennethresearch.com/report-details/global-pharmaceutical-contract-manufacturing-market/10065061

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name: David
Email : Sales@kennethresearch.com
Phone:+1 313 462 0609

This release was published on openPR.